Carisma Therapeutics Inc share price logo

Carisma Therapeutics Inc Share Price

NASDAQ: CARM

Small Cap

$0.32

-0.02

(-4.96%)

as on

Carisma Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $0.31
    $0.34
    downward going graph

    3.13%

    Downside

    6.25%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.14
    $1.27
    downward going graph

    55.72%

    Downside

    296.88%

    Upside

    downward going graph

Carisma Therapeutics Inc share price movements today

Previous Close
$0.34
Open
$0.33
Volume
993.1K
Day's Low - High
$0.31 - $0.34
52 Week Low - High
$0.14 - $1.27

Carisma Therapeutics Inc Historical Returns

1 Month Return
+ 15.24 %
3 Month Return
-25.22 %
1 Year Return
-66.35 %
3 Year Return
0 %
5 Year Return
0 %

Carisma Therapeutics Inc Stock Fundamentals & Key Indicators

Check Carisma Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.5M

EPS (TTM)

-0.69

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.62

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-42.0M

Revenue (TTM)

10.8M

Profit Margin

0.00%

Return On Equity TTM

4160800.00%

Carisma Therapeutics Inc Stock Valuation

Track how Carisma Therapeutics Inc P/E has moved over time to understand its valuation trends.

Carisma Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (-0.62x)

September 17, 2025

Highest (-0.21x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.62x

Carisma Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Carisma Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$14.5MNA-0.620.00%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Carisma Therapeutics Inc Stock including INR - Dollar returns

The Carisma Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Carisma Therapeutics Inc investment value today

Current value as on today

₹36,598

Returns

₹63,402

(-63.4%)

Returns from Carisma Therapeutics Inc Stock

₹68,000 (-68%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Carisma Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Carisma Therapeutics Inc. Average target price of $1

Carisma Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Carisma Therapeutics Inc.

What analysts predicted

68%UPSIDE

Target Price

$1

Current Price

$0.32

Analyzed by

12 Analysts

Target

$1.00

Carisma Therapeutics Inc target price $1, a slight upside of 68% compared to current price of $0.32. According to 12 analysts rating.

Carisma Therapeutics Inc Stock's Interest Amongst Investors

Investment in Carisma Therapeutics Inc Shares on INDmoney has grown by 386.66% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:386.66% versus previous 30 day period

Search interest for Carisma Therapeutics Inc Stock has increased by 309% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:309% versus previous 30 day period

Carisma Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
3
3
3
4
3
9
3
3
3
-
Gross Profit
2
2
3
-
1
8
3
2
3
0
Operating Income
-22
-20
-22
-22
-19
-11
-13
-17
-9
-5
EBITDA
-22
-20
-21
-
-17
-11
-12
-15
-8
-5
Interest Expense
1
-
-
-
0
0
-
-
-
-
Depreciation
0
0
0
0
1
0
0
0
0
-
Income Before Tax
-24
-19
-21
-21
-18
-11
-12
-17
-9
-9
Income Tax Expense
0
0
0
-
0
-
-
-
-
-
Net Income
-24
-19
-21
-20
-18
-11
-12
-17
-9
-9
Net Profit Margin
-759.85%
-558.31%
-559.26%
-488.65%
-558.67%
-121.37%
-375.24%
-482.75%
-248.48%
0.00%

Carisma Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
29
0
11
26
9
14
19
Gross Profit
0
29
0
11
26
3
-59
-40
Operating Income
-35
6
-19
-28
-40
-56
-88
-62
EBITDA
-31
2
-28
-27
-40
-51
-85
-57
Interest Expense
1
0
-
1
8
3
1
-
Depreciation
-
-
-
0
0
1
2
3
Income Before Tax
-33
1
-29
-28
-40
-61
-86
-60
Income Tax Expense
1
0
-
0
0
-3
8
-60
Net Income
-33
1
-29
-28
-40
-61
-86
-60
Net Profit Margin
-3378.99%
6.31%
-6830.35%
-252.31%
-153.65%
-622.60%
-582.34%
-308.05%

Carisma Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-19
-21
-20
-18
-11
-12
-17
-9
-9
Operating Cash Flow
-18
-20
-16
-22
-16
-13
-8
-10
-5
Investing Cash Flow
35
29
-
0
0
-56
-
0
0
Financing Cash Flow
-3
-2
0
1
0
0
0
0
-
Change in Cash
13
6
-5
-21
-16
-13
-8
-10
-5

Carisma Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
1
-29
-33
-107
-28
-40
-61
-86
-60
Operating Cash Flow
2
-17
-22
-37
-27
-37
-7
-81
-59
Investing Cash Flow
0
0
0
0
0
-1
-32
72
0
Financing Cash Flow
-13
7
58
35
72
15
35
62
0
Change in Cash
-10
-10
35
-2
44
-23
-138
53
-59

Insights on Carisma Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 3.38M → 3.72M (in $), with an average increase of 4.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 134.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CARM stock has moved down by -14.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -9.26M → -9.77M (in $), with an average decrease of 5.5% per quarter

About Carisma Therapeutics Inc

eleven biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. eleven biotherapeutics' scientists are engineering protein-based drugs using newly available structural information and the company’s unique molecular understanding of clinical effects to create the next generation of protein-based medicines to treat important diseases with unmet needs, such as inflammatory conditions and coagulation disorders.
OrganisationCarisma Therapeutics Inc
Headquarters3675 Market Street, Philadelphia, PA, United States, 19104
CEOMr. Steven Kelly
E-voting on sharesClick here to vote

Key Management of Carisma Therapeutics Inc

Name

Title

Ms. Natalie McAndrew

Vice President of Finance

Mr. Steven Kelly

President, CEO & Director

Mr. Michael Klichinsky Ph.D., Pharm.D., PharmD

Co-Founder & Chief Scientific Officer

Dr. Saar Gill M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

FAQs

What is Carisma Therapeutics Inc share price today?

Carisma Therapeutics Inc share price today is $0.32 as on at the close of the market. Carisma Therapeutics Inc share today touched a day high of $0.34 and a low of $0.31.

What is the 52 week high and 52 week low for Carisma Therapeutics Inc share?

Carisma Therapeutics Inc share touched a 52 week high of $1.27 on and a 52 week low of $0.14 on . Carisma Therapeutics Inc stock price today i.e. is closed at $0.32,which is 74.80% down from its 52 week high and 125.83% up from its 52 week low.

What is Carisma Therapeutics Inc's market capitalisation today?

Carisma Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Carisma Therapeutics Inc Stock (CARM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Carisma Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Carisma Therapeutics Inc Shares that will get you 4.6875 shares as per Carisma Therapeutics Inc share price of $0.32 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Carisma Therapeutics Inc Stock (CARM) from India?

Indian investors can start investing in Carisma Therapeutics Inc (CARM) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Carisma Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Carisma Therapeutics Inc share’s latest price of $0.32 as on September 18, 2025 at 1:29 am IST, you will get 31.2500 shares of Carisma Therapeutics Inc. Learn more about fractional shares .